Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis
Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous PolyposisUnderscores unmet need for a ...
Too Old to Operate5d
Headache in pituitary adenomas: frequency, characteristics and outcome after treatment.
Headache is common among patients diagnosed with pituitary adenoma (PA). There are still controversies regarding the headache presentation, pathophysiology and outcome after treatment in these ...
Healio12d
Stool DNA testing ‘can be performed safely’ regardless of anticoagulant, antiplatelet use
Oral anticoagulant or antiplatelet medication use had no substantial effect on the accuracy of multitarget stool DNA testing for colorectal cancer, according to a study published in Gastro Hep ...
verywellhealth14d
Adenomatous Polyp in the Colon
Adenomatous polyps typically do not cause symptoms unless they progress to colon cancer. Even then, there may be no sign of a problem until the malignancy is advanced. This is why colon cancer ...
Frontiers1mon
Case report: Detection and treatment of a rare submucosal gland duct adenoma of the esophagus
1 Department of Gastroenterology, Xuancheng People’s Hospital, Anhui, China 2 Electrocardiogram Room, Huai’an Third People’s Hospital, Jiangsu, China This article reports a rare case of esophageal ...
Pharmaceutical Technology1mon
ALM-412 by Almirall for Familial Adenomatous Polyposis: Likelihood of Approval
ALM-412 is under clinical development by Almirall and currently in Phase I for Familial Adenomatous Polyposis. According to GlobalData, Phase I drugs for Familial Adenomatous Polyposis have a 78% ...